Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Prall

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Histopathology|November 19, 2011
Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially curative resections with long-term follow-upMichael Wöhlke, Leif Schiffmann, Friedrich Prall
World Journal of Surgical Oncology|April 22, 2015
Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological studyFriedrich Prall, Oliver Schmitt, Leif Schiffmann
Histopathology|October 18, 2012
Microdensitometry of osteopontin as an immunohistochemical prognostic biomarker in colorectal carcinoma tissue microarrays: potential and limitations of the method in 'biomarker pathology'Friedrich Prall, Claudia Maletzki, Michael Linnebacher
International Journal of Oncology|July 7, 2009
Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classificationChristiane Ostwald, Michael Linnebacher, Volker Weirich, et al.
Journal of Visualized Experiments : Jove|December 10, 2019
Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower LegChristian Klopsch, Alexander Kaminski, Friedrich Prall, et al.
Human Pathology|May 2, 2006
p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor buddingFriedrich Prall, Christiane Ostwald, Volker Weirich, et al.
Oncology Reports|June 6, 2007
Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?Friedrich Prall, Christiane Ostwald, Leif Schiffmann, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 10, 2004
Expression profiling of colorectal carcinomas using tissue microarrays: cell cycle regulatory proteins p21, p27, and p53 as immunohistochemical prognostic markers in univariate and multivariate analysisFriedrich Prall, Christiane Ostwald, Horst Nizze, et al.
Human Pathology|January 9, 2018
Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain?Maja Hühns, Saskia Krohn, Hugo Murua Escobar, et al.
Frontiers in Oncology|May 25, 2023
Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer <i>in vitro</i> models including the rare pleomorphic subentityIngo Andus, Friedrich Prall, Michael Linnebacher, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Histopathology|November 19, 2011
Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially curative resections with long-term follow-upMichael Wöhlke, Leif Schiffmann, Friedrich Prall
World Journal of Surgical Oncology|April 22, 2015
Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological studyFriedrich Prall, Oliver Schmitt, Leif Schiffmann
Histopathology|October 18, 2012
Microdensitometry of osteopontin as an immunohistochemical prognostic biomarker in colorectal carcinoma tissue microarrays: potential and limitations of the method in 'biomarker pathology'Friedrich Prall, Claudia Maletzki, Michael Linnebacher
International Journal of Oncology|July 7, 2009
Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classificationChristiane Ostwald, Michael Linnebacher, Volker Weirich, et al.
Journal of Visualized Experiments : Jove|December 10, 2019
Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower LegChristian Klopsch, Alexander Kaminski, Friedrich Prall, et al.
Human Pathology|May 2, 2006
p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor buddingFriedrich Prall, Christiane Ostwald, Volker Weirich, et al.
Oncology Reports|June 6, 2007
Do thymidylate synthase gene promoter polymorphism and the C/G single nucleotide polymorphism predict effectiveness of adjuvant 5-fluorouracil-based chemotherapy in stage III colonic adenocarcinoma?Friedrich Prall, Christiane Ostwald, Leif Schiffmann, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 10, 2004
Expression profiling of colorectal carcinomas using tissue microarrays: cell cycle regulatory proteins p21, p27, and p53 as immunohistochemical prognostic markers in univariate and multivariate analysisFriedrich Prall, Christiane Ostwald, Horst Nizze, et al.
Human Pathology|January 9, 2018
Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain?Maja Hühns, Saskia Krohn, Hugo Murua Escobar, et al.
Frontiers in Oncology|May 25, 2023
Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer <i>in vitro</i> models including the rare pleomorphic subentityIngo Andus, Friedrich Prall, Michael Linnebacher, et al.
Pageof 7